PRONEC LIMITED

Active Macclesfield

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
P

PRONEC LIMITED

Research and experimental development on biotechnology

Founded 14 Sept 2015 Active Macclesfield, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 15 Aug 2024 Next due 31 Dec 2025 4 months overdue
Confirmation Submitted 17 Sept 2025 Next due 18 Aug 2026 3 months remaining
Net assets £-121K £90 2023 year on year
Total assets £2K £0 2023 year on year
Total Liabilities £122K £90 2023 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Biohub At Alderley Park Alderley Park Alderley Edge Macclesfield Cheshire SK10 4TG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PRONEC LIMITED (09775968), an active company based in Macclesfield, England. Incorporated 14 Sept 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2016–2023)

Cash in Bank

N/A

Net Assets

-£120.57k

Decreased by £90.00 (-0%)

Total Liabilities

£122.39k

Increased by £90.00 (+0%)

Turnover

N/A

Employees

N/A

Debt Ratio

6703%

Increased by 5 (+0%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2017Seed
Investor 2Apr 2017Seed
Investor 3Apr 2017Seed

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 240 Shares £288k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Sept 2015240£288k£1k

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (7)

Hilmar Meek Warenius
42.9%
Gm & Cheshire Life Science Fund
18.4%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Hilmar Meek Warenius

British

Active
Notified 6 Apr 2016
Residence England
DOB January 1942
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026DissolutionDissolved Compulsory Strike Off Suspended
3 Mar 2026GazetteGazette Notice Compulsory
17 Sept 2025Confirmation StatementConfirmation statement made on 2025-08-04 with no updates
25 Oct 2024OfficersTermination of Graham Hine as director on 2024-10-23
25 Oct 2024OfficersTermination of Nigel Keith Davis as director on 2024-10-23
21 Apr 2026 Dissolution

Dissolved Compulsory Strike Off Suspended

3 Mar 2026 Gazette

Gazette Notice Compulsory

17 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-08-04 with no updates

25 Oct 2024 Officers

Termination of Graham Hine as director on 2024-10-23

25 Oct 2024 Officers

Termination of Nigel Keith Davis as director on 2024-10-23

Recent Activity

Latest Activity

Dissolved Compulsory Strike Off Suspended

1 days ago on 21 Apr 2026

Gazette Notice Compulsory

1 months ago on 3 Mar 2026

Confirmation statement made on 2025-08-04 with no updates

7 months ago on 17 Sept 2025

Termination of Graham Hine as director on 2024-10-23

1 years ago on 25 Oct 2024

Termination of Nigel Keith Davis as director on 2024-10-23

1 years ago on 25 Oct 2024